Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSysgroup Regulatory News (SYS)

Share Price Information for Sysgroup (SYS)

Share Price is delayed by 15 minutes
Get Live Data
18.00    0.00 (0.00%)
Bid:
17.00
Ask:
19.00
Spread: 2.00 (11.765%)
Market Cap: £15.07m
SYS Live PriceLast checked at - London Stock Exchange

Intraday Sysgroup Share Chart

Final Trading Statement

26 Nov 2009 07:00

RNS Number : 1058D
System C Healthcare plc
26 November 2009
 



System C Healthcare plc

Pre-Close Trading Update

System C Healthcare plc (AIM: SYS) ("System C" or "the Company"), a leading provider of information solutions and services to the health and social care sector, is pleased to provide the following trading update for the six months ending 30 November 2009, prior to entering its close period.

Revenues, profit and cash have continued to grow as forecast, and the Company is on track to meet consensus market expectations for the full year. Significant increases in revenues and profits over the same period in 2008/9 reflect both strong organic growth and the impact of the acquisitions of Liquidlogic and Bluestar.

Products

Sales and deployments of System C's flagship Medway Sigma product suite continue to progress well. Over the last six months the Company has deployed 11 Medway Sigma products, including a clinical information system at Aintree University Hospitals NHS Foundation Trust, multiple deployments of its dashboard and portal modules, and an island-wide social services system and pilot ambulance system for the Isle of Man government. A contract with NHS Connecting for Health, to develop and install clinical intelligence systems in NHS Trusts, is making good progress. The Company is now looking to benefit from the ASCC framework contract that it holds with the NHS as trusts across the South of England procure the next generation of centrally-funded computer systems.

Liquidlogic, acquired in July 2009 for a consideration of up to £14.2m, has continued to gain market share in the social care sector. One of the main drivers behind the Liquidlogic transaction was to provide integrated care solutions across the health and social care sectors, and work has already begun on a number of cross-organisational projects. 

Services

Services revenues have grown significantly in line with projections. Activity has continued to increase in the Company's stronghold area of deploying a wide range of third party systems for NHS trusts across the UK. The Company also remains heavily involved in deploying third party products from iSoft and Cerner under the National Programme for IT, with both NHS Connecting for Health and Local Service Providers as clients. 

Dr Ian Denley, CEO of System C, said: "We are continuing to benefit from our reputation for quality and delivery. This, together with the strong synergy between the products and services divisions, is driving our sales growth.

"We continue to expand and develop our product range, in line with the strategy we have set out previously, and product sales now account for approximately 50% of revenues.

We see many opportunities in both the product and services business and remain confident of reporting continuing progress through the second half of the year."

For further information please contact:

System C Healthcare plc

Tel: 01622 691616

Dr Ian Denley, Chief Executive

Andrew Coll, Finance Director

Charles Stanley Securities (Nominated Adviser)

Tel: 020 7149 6000

Russell Cook / Jen Boorer

Maitland (Financial and Corporate Communications)

Tel: 020 7379 5151

Emma Burdett/Richard Farnsworth

Notes to editors

System C Healthcare plc (www.systemc.com), specialises in the design and development of clinical patient management and business intelligence software, and provides systems implementation and consulting services to the health sector.

System C Healthcare is quoted on the AIM market of the London Stock Exchange.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTCKPKQFBDDQDB
Date   Source Headline
20th Dec 20189:48 amRNSHolding(s) in Company
20th Dec 20189:47 amRNSHolding(s) in Company
27th Nov 20187:00 amRNSGrant of Options
26th Nov 20182:40 pmRNSDirector's Share Purchase
26th Nov 20187:00 amRNSHalf-year Report
1st Nov 20187:00 amRNSNotice of Results
21st Sep 201811:17 amRNSResult of AGM
11th Sep 201811:32 amRNSHolding(s) in Company
24th Jul 20181:30 pmRNSReplacement: Notice of AGM and Board Change
24th Jul 20187:00 amRNSNotice of AGM
16th Jul 20187:00 amRNSLTIP Grant
2nd Jul 201812:43 pmRNSReplacement Implementation of LTIP & initial grant
29th Jun 20187:00 amRNSImplementation of LTIP and initial grant
27th Jun 20187:01 amRNSAppointment of a Director and Board transition
27th Jun 20187:00 amRNSFinal Results
6th Jun 20187:00 amRNSNotice of Results
21st May 20189:14 amRNSHolding(s) in Company
21st May 20189:10 amRNSHolding(s) in Company
23rd Apr 20187:00 amRNSTrading Update and Notice of Results
3rd Apr 20187:00 amRNSBoard Changes and launch of new investor website
5th Mar 20187:00 amRNSContract Win
26th Jan 20182:19 pmRNSDirector's Share Purchase
8th Jan 20187:00 amRNSAppointment of Non-Executive Director to the Board
6th Dec 20177:00 amRNSHalf-year Report
7th Nov 20171:58 pmRNSHolding(s) in Company
7th Nov 20177:00 amRNSBoard Changes
6th Nov 20177:00 amRNSTrading Update
3rd Nov 20172:36 pmRNSHolding(s) in Company
2nd Nov 20177:00 amRNSNotice of Results
1st Nov 20177:00 amRNSAcquisition of Rockford IT
31st Oct 20177:00 amRNSAppointment of COO to the Board
23rd Oct 20177:00 amRNSDirectorate Change
20th Sep 201712:44 pmRNSHolding(s) in Company
25th Aug 20172:37 pmRNSResult of AGM
24th Aug 20177:00 amRNSDirector/PDMR Shareholding
23rd Aug 20172:27 pmRNSHolding(s) in Company
22nd Aug 20173:51 pmRNSDirector and PDMR share purchases
24th Jul 20177:00 amRNSDirector's share purchase
12th Jul 201710:30 amRNSAvailability of Annual Accounts & Notice of AGM
7th Jun 20177:00 amRNSFinal Results
2nd May 20174:08 pmRNSFurther Trading Update
6th Apr 20172:00 pmRNSGrant of Options and Director/PDMR Disclosure
6th Apr 20177:00 amRNSTrading Update, Board Appointment
16th Mar 20175:00 pmRNSHolding(s) in Company
7th Mar 20178:05 amRNSCorrection: Payment of Deferred Consideration
7th Mar 20177:00 amRNSDeferred Consideration and Issue of Equity re Q4Ex
20th Feb 20173:00 pmRNSHolding(s) in Company
14th Feb 20177:00 amRNSDeferred Consideration and Issue of Equity re Q4Ex
23rd Jan 20177:00 amRNSAppointment of Chief Financial Officer
21st Dec 20163:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.